Myriad Genetics, Inc. (NASDAQ:MYGN) Given Average Rating of Hold by Brokerages

Shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) have received an average recommendation of “Hold” from the six analysts that are presently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and three have assigned a buy recommendation to the company. […]

Related Keywords

United States ,Wellington ,New Zealand General ,New Zealand , ,Sei Investments Co ,Wellington Management Group ,Genetics Company Profile ,Genetics Inc ,Nasdaq ,Earnest Partners ,Goldman Sachs Group ,Glenview Capital Management ,Vanguard Group Inc ,Myriad Genetics ,Get Free Report ,Genetics Stock Down ,Capital Management ,Management Group ,Get Free ,Myrisk Hereditary Cancer Test ,Germline Companion Diagnostic Test ,Companion Diagnostic Test ,Myriad Genetics Daily ,Nasdaq Mygn ,Mygn ,Medical ,62855j10 ,Ratings ,Consensus ,